A Day Up For Cassava Sciences, Inc.

Cassava Sciences, Inc. (SAVA:NASDAQ) rocketted at $58.07, a gain of 25.9%. On Mon, Nov 01, 2021, SAVA:NASDAQ hit a New 2-Week Intraday Low of $42.18. The stock got featured on our News Catalysts scanner on Sun, Oct 31, 2021 at 05:16 AM in the 'BIOTECH' category. From Mon, Oct 18, 2021, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Thu, Aug 12, 2021 at $126.51 with a volume of 676M+, and its share price has been moving sideways in recent weeks.

About Cassava Sciences, Inc. (SAVA:NASDAQ)

Pain Therapeutics Inc is a biopharmaceutical company. It develops proprietary drugs that offer improvements to patients and healthcare professionals. The company generally focuses on the drug development efforts on disorders of the nervous system, such as chronic pain. Pain Therapeutics operates in the single operating segment. Pain Therapeutics's drug candidate, REMOXY, is an abuse-deterrent, oral formulation of oxycodone (CII). The company's other product includes FENROCK. REMOXY is a painkiller with a formulation designed to reduce potential risks of unintended use.